Cancer treatment could become more affordable for thousands of patients across India as new pricing measures for 137 anti-cancer medicines . The National Pharmaceutical Pricing Authority (NPPA) has introduced a trade margin cap of 30% on these medicines, aiming to reduce excessive markups across the pharmaceutical supply chain.
The decision is expected to provide financial relief to patients and families who face significant expenses during cancer treatment.
137 Anti-Cancer Medicines Covered
The latest pricing initiative covers 137 non-scheduled anti-cancer medicines. Several important medicines used in cancer treatment are included in the list, such as:
- Denosumab
- Pegfilgrastim
- Bevacizumab
- Pembrolizumab
- Durvalumab
- Osimertinib
These medicines are used in the treatment of different cancers and related complications.
Prices May Decline by Up to 70%
Under the new arrangement, trade margins across the distribution and retail chain will be restricted to 30%.
As a result, some medicines could become cheaper by as much as 70%. However, the actual reduction will differ from one medicine to another depending on its existing price and distribution structure.
The maximum reduction should not be interpreted as a uniform price cut across all 137 medicines.
Pharmacies and Hospitals Must Follow Revised Prices
Pharmacies, retailers, hospitals and medical institutions are required to charge the revised prices and display updated price information for consumers.
Manufacturers must also notify the NPPA about revised prices within seven days of the relevant Gazette notification.
State Drug Controllers will monitor compliance to ensure that the new pricing requirements are followed.
What Does This Mean for Cancer Patients?
The initiative is expected to improve the affordability of several important cancer medicines and reduce the financial pressure on patients undergoing treatment.
The government has also directed manufacturers to maintain existing production and supply levels to prevent shortages.
Patients and families can check updated medicine prices through the official NPPA website and the Pharma Sahi Daam mobile application.
The latest decision marks an important step towards making cancer treatment more financially accessible while strengthening transparency in medicine pricing.
